-
Yum! Brands Opens 871 New Restaurants While Navigating A Slower Quarter
Tuesday, August 5, 2025 - 9:09am | 460Read More...Yum! Brands, Inc. (NYSE:YUM) shares traded lower in the premarket session on Tuesday. The company reported second-quarter adjusted earnings per share of $1.44, missing the analyst consensus estimate of $1.46. Quarterly sales of $1.93 billion missed the Street view of $1.939 billion. Company...
-
Icahn Enterprises Narrows Q2 Loss But Misses EPS Forecast In Tough Energy Quarter
Monday, August 4, 2025 - 12:24pm | 502Read More...Icahn Enterprises L.P. (NASDAQ:IEP) on Monday reported a second-quarter net loss of $165 million, or 30 cents per depositary unit. It missed analyst expectations of a 14-cent profit and narrowed from a loss of $331 million, or 72 cents per unit, in the year-ago quarter. Net sales for the quarter...
-
Joby Teams With L3Harris To Build Hybrid Military Aircraft, Shares Surge On Bold Defense Bet
Friday, August 1, 2025 - 12:55pm | 443Read More...Joby Aviation Inc. (NYSE:JOBY) and L3Harris Technologies (NYSE:LHX) announced Friday that they are partnering to develop a hybrid vertical takeoff and landing aircraft designed for U.S. military use. The gas turbine-powered aircraft will be capable of crewed and fully autonomous operations,...
-
PulteGroup Posts Solid Earnings, But Revenue Misses—What's Next For The Homebuilder?
Tuesday, July 22, 2025 - 9:11am | 477Read More...Rising interest rates and economic uncertainties are reshaping the landscape for homebuilders, challenging companies to adapt their strategies. As the housing market navigates these shifts, PulteGroup Inc. (NYSE:PHM) stands out with its latest financial performance, revealing both the pressures and...
-
Snap-On Tools Segment Drives Growth While Margins Tighten In Q2 Beat
Thursday, July 17, 2025 - 10:52am | 461Read More...Snap-On Inc. (NYSE:SNA) reported better-than-expected second-quarter 2025 results, surpassing both revenue and earnings consensus estimates. Here's a breakdown of the report: Quarterly net sales reached $1.179 billion flat year-over-year increase and above the consensus estimate of $1.16 billion....
-
Pfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook
Monday, July 14, 2025 - 2:39pm | 510Read More...Bank of America (BofA) Securities updated the earnings model for Pfizer Inc. (NYSE:PFE). The company will announce second-quarter 2025 earnings on August 5. According to data from Benzinga Pro, analysts estimate adjusted earnings of 57 cents per share on sales of $13.41 billion. In the second...
-
Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery
Monday, July 14, 2025 - 2:15pm | 354Read More...Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) on Sunday presented new exploratory analyses from its Phase 2 PREVENT and Phase 2b trials of avexitide—an investigational GLP-1 receptor antagonist—at the Endocrine Society's annual meeting (ENDO 2025). The drug targets post-bariatric hypoglycemia (PBH),...
-
Nebius Emerges As Neutral AI Cloud Alternative, Deepens Ties With Nvidia, OpenAI, Microsoft: Analyst
Monday, July 14, 2025 - 1:27pm | 819Read More...Nebius Group (NASDAQ:NBIS) stock surged on Monday after Goldman Sachs analyst Alexander Duval initiated coverage with a Buy rating and announced a price target of $68. Duval noted that Nebius is emerging as a key player in the fast-growing AI Neoclouds space — a niche segment within the broader GPU...
-
FDA Delays Approval For Ultragenyx's Gene Therapy, But Not A Dealbreaker, Says Analyst
Monday, July 14, 2025 - 1:05pm | 548Read More...The U.S. Food and Drug Administration issued on Friday a Complete Response Letter for Ultragenyx Pharmaceutical Inc.’s (NASDAQ:RARE) Biologics License Application (BLA) for UX111 (ABO-102) AAV gene therapy for Sanfilippo syndrome type A (MPS IIIA). In the CRL, the FDA requested that the...
-
Elevance Steps In As UnitedHealth Delays — Will It Set The Tone For Insurers?
Monday, July 14, 2025 - 11:38am | 597Read More...Health insurer Elevance Health Inc. (NYSE:ELV) is scheduled to release its second quarter 2025 financial results on July 17. Analysts estimate adjusted earnings of $9.197 per share on sales of $48.24 billion, as per data from Benzinga Pro. UnitedHealth Group Inc. (NYSE:UNH) has been the first major...
-
Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday?
Monday, July 14, 2025 - 11:30am | 328Read More...Sonnet BioTherapeutics Inc. (NASDAQ:SONN) stock surged Monday amid high trading volume following news of a transformative business combination with Rorschach I, backed by Atlas Merchant Capital and Paradigm. The deal will create Hyperliquid Strategies Inc., a public cryptocurrency treasury company...
-
XCF Global Bets Big On Sustainable Aviation Fuel With $1 Billion Investment
Thursday, July 10, 2025 - 10:51am | 627Read More...XCF Global, Inc. (NASDAQ:SAFX) stock is trading higher on Thursday, with a session volume of 95.7 million compared to the average volume of 6.21 million as per data from Benzinga Pro. A key player in decarbonizing the aviation industry through Synthetic Aviation Fuel (SAF), the company shared its...
-
Enphase Expands Smart EV Charging Footprint Across Europe
Thursday, July 10, 2025 - 10:34am | 390Read More...Enphase Energy Inc. (NASDAQ:ENPH) on Thursday announced that it has expanded the rollout of its IQ EV Charger 2 to four additional European countries, Greece, Romania, Ireland, and Poland. The charger can function either alongside Enphase solar and battery systems or as a standalone unit for...
-
Why Is BIT Mining Stock Skyrocketing On Thursday?
Thursday, July 10, 2025 - 10:16am | 488Read More...BIT Mining Limited (NYSE:BTCM) stock is trading higher on Thursday, with a session volume of 79.2 million compared to the average volume of 67.6K as per data from Benzinga Pro. BIT Mining announced a strategic shift on Thursday with its expansion into the Solana ecosystem, marking a critical...
-
Why Helen Of Troy Stock Is Falling Today
Thursday, July 10, 2025 - 10:16am | 511Read More...Helen of Troy Limited (NASDAQ:HELE) saw its shares tumble by over 20% on Thursday after the company reported a disappointing first quarter. The stark miss not only highlights the company’s struggles under the weight of ongoing tariff pressures but also raises serious concerns for investors...
















